These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8246036)

  • 41. Comparisons of outcomes and survivals for two central venous access port systems.
    Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
    J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
    Clifton GD; Branson P; Kelly HJ; Dotson LR; Record KE; Phillips BA; Thompson JR
    Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of saline for i.v. locks in children.
    Hanrahan KS; Kleiber C; Fagan CL
    Pediatr Nurs; 1994; 20(6):549-52. PubMed ID: 7708453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
    Schallom ME; Prentice D; Sona C; Micek ST; Skrupky LP
    Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of heparin versus saline solution on intermittent infusion device irrigation.
    Ashton J; Gibson V; Summers S
    Heart Lung; 1990 Nov; 19(6):608-12. PubMed ID: 2228650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Normal saline flush vs. dilute heparin flush.
    Gardner C
    J Intraven Nurs; 1988; 11(3):206. PubMed ID: 3373368
    [No Abstract]   [Full Text] [Related]  

  • 47. Normal saline vs. heparin lock flush solution: one institution's findings.
    Miracle V; Fangman B; Kayrouz P; Kederis S; Pursell L
    Ky Nurse; 1989; 37(3):1, 6-7. PubMed ID: 2761272
    [No Abstract]   [Full Text] [Related]  

  • 48. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters.
    Haire WD; Lieberman RP; Lund GB; Edney JA; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1991 Jan; 7(1):57-9. PubMed ID: 1675136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Questions raised regarding double blind comparison research.
    Toth LA; Robertson J
    Pediatr Nurs; 1996; 22(1):80, 79. PubMed ID: 8700633
    [No Abstract]   [Full Text] [Related]  

  • 50. Heparin added to infused fluids.
    Meyerowitz BR
    West J Med; 1987 Jan; 146(1):101. PubMed ID: 3825101
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of circulating heparin in cancer patients after port flush of indwelling venous access devices: implications for bevacizumab-associated thrombosis.
    Amirkhosravi A; Meyer T; Hatfield M; Desai H; Amaya M; Drexler A; Reyes E; Barranco J; Rathmann K; Bigsby G; Francis JL
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):176-7. PubMed ID: 22270797
    [No Abstract]   [Full Text] [Related]  

  • 52. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy.
    Gershman MD; Kennedy DJ; Noble-Wang J; Kim C; Gullion J; Kacica M; Jensen B; Pascoe N; Saiman L; McHale J; Wilkins M; Schoonmaker-Bopp D; Clayton J; Arduino M; Srinivasan A;
    Clin Infect Dis; 2008 Dec; 47(11):1372-9. PubMed ID: 18937575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scanning electron microscopic comparison between the thrombogenic properties of heparinized and non-heparinized vena cava catheters. A long-term study.
    Wenning M; Höpker WW
    Virchows Arch A Pathol Anat Histol; 1981; 391(2):207-15. PubMed ID: 7222474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices.
    Benner K; Lucas AJ
    Am J Health Syst Pharm; 2012 Jul; 69(14):1252-4. PubMed ID: 22761082
    [No Abstract]   [Full Text] [Related]  

  • 56. Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter.
    Ball CL; Tobler K; Ross BC; Connors MR; Lyon ME
    Clin Chem Lab Med; 2004 Jan; 42(1):107-8. PubMed ID: 15061391
    [No Abstract]   [Full Text] [Related]  

  • 57. QUESTION 3. Cannula patency: should we use flushes or continuous fluids, or heparin?
    Pryce R
    Arch Dis Child; 2009 Dec; 94(12):992-4. PubMed ID: 19933609
    [No Abstract]   [Full Text] [Related]  

  • 58. National survey of central venous catheter flushing in the intensive care unit.
    Sona C; Prentice D; Schallom L
    Crit Care Nurse; 2012 Feb; 32(1):e12-9. PubMed ID: 22298726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thrombosis of the vascular access in hemodialysis patients. Rationale for the preventive use of olive oil].
    Villarrubia VG; Gil-Cunquero JM; Pérez-Bañasco V
    Nefrologia; 2007; 27(2):122-33. PubMed ID: 17564556
    [No Abstract]   [Full Text] [Related]  

  • 60. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.